Selected papers, reports and websites
Not in any particular order
Origins and spread
- A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence
- Pathology of guinea pigs experimentally infected with a novel reovirus and coronavirus isolated from SARS patients.
- SARS-CoV and emergent coronaviruses: viral determinants of interspecies transmission
- Evidence for ACE2-Utilizing Coronaviruses (CoVs) Related to Severe Acute Respiratory Syndrome CoV in Bats
- Difference in Receptor Usage between Severe Acute Respiratory Syndrome (SARS) Coronavirus and SARS-Like Coronavirus of Bat Origin
Event 201 was a 3.5-hour pandemic tabletop exercise that simulated a series of dramatic, scenario-based facilitated discussions, confronting difficult,
true-to-life dilemmas associated with response to a hypothetical, but scientifically plausible, pandemic. 15 global business, government, and public health
leaders were players in the simulation exercise that highlighted unresolved real-world policy and economic issues that could be solved with sufficient
political will, financial investment, and attention now and in the future.
The event was held on Friday, October 18, 2019, at the Pierre Hotel in New York, under the auspices of the John Hopkins Center for Health Security, the World Economic Forum, and the Bill & Melida Gates Foundation.
Event 201 simulates an outbreak of a novel zoonotic coronavirus transmitted from bats to pigs to people that eventually becomes efficiently transmissible from person to person,
leading to a severe pandemic. The pathogen and the disease it causes are modeled largely on SARS, but it is more transmissible in the community setting by people with mild symptoms.
The ficticious virus/disease used in this exercise was called CAPS (Coronavirus Acute Pulmonary Syndrome).
Also see the videos.
- The Proximal Origin of SARS-CoV-2
- The Novel Coronavirus, 2019-nCoV, is Highly Contagious and More Infectious Than Initially Estimated
- Preparedness and vulnerability of African countries against importations of COVID-19: a modelling study
- Deposition of respiratory virus pathogens on frequently touched surfaces at airports
- Return of the Coronavirus: 2019-nCoV
- SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients
- Defining the Epidemiology of Covid-19 — Studies Needed
- Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany
- Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China
- Novel Coronavirus Infection in Hospitalized Infants Under 1 Year of Age in China
- Diversity of coronavirus in bats from Eastern Thailand
- A strategy to prevent future epidemics similar to the 2019-nCoV outbreak
- Serological Evidence of Bat SARS-Related Coronavirus Infection in Humans
- Reviewing the History of Pandemic Influenza: Understanding Patterns of Emergence and Transmission
- Presumed Asymptomatic Carrier Transmission of COVID-19
- Looming threat of COVID-19 infection in Africa: act collectively, and fast
- Genomic epidemiology of novel coronavirus (HCoV-19)
- On the origin and continuing evolution of SARS-CoV-2
- Composition and divergence of coronavirus spike proteins and host ACE2 receptors predict potential intermediate hosts of SARS-CoV-2.
- Comparative genetic analysis of the novel coronavirus (2019-nCoV/SARS-CoV-2) receptor ACE2 in different populations
- A Hint on the COVID-19 Risk: Population Disparities in Gene Expression of Three Receptors of SARS-CoV
- Asians Do Not Exhibit Elevated Expression or Unique Genetic Polymorphisms for ACE2, the Cell-Entry Receptor of SARS-CoV-2
- Receptor recognition by novel coronavirus from Wuhan: An analysis based on decade-long structural studies of SARS
- Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis.
- Nicotine and the renin-angiotensin system.
- High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa.
- Aerosol and surface stability of HCoV-19 (SARS-CoV-2) compared to SARS-CoV-1
- Coronavirus Disease 2019: Coronaviruses and Blood Safety
- Impact of non-pharmaceutical interventions (NPIs) to reduce COVID-19 mortality and healthcare demand
- Estimating the number of infections and the impact of non-pharmaceutical interventions on COVID-19 in 11 European countries
- Review of Ferguson et al “Impact of non-pharmaceutical interventions...”
- Relationship between the ABO Blood Group and the COVID-19 Susceptibility
- Loss of sense of smell as marker of COVID-19 infection
- Estimating clinical severity of COVID-19 from the transmission dynamics in Wuhan, China
- High Temperature and High Humidity Reduce the Transmission of COVID-19
- The effect of control strategies to reduce social mixing on outcomes of the COVID-19 epidemic in Wuhan, China: a modelling study
- Structural basis of receptor recognition by SARS-CoV-2
- Epidemiology of Covid-19 in a Long-Term Care Facility in King County, Washington
- Will Coronavirus Pandemic Diminish by Summer?
- High Temperature and High Humidity Reduce the Transmission of COVID-19
- Turbulent Gas Clouds and Respiratory Pathogen Emissions: Potential Implications for Reducing Transmission of COVID-19
- A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version)
- Practical recommendations for critical care and anesthesiology teams caring for novel coronavirus (2019-nCoV) patients
- Vital Surveillances: The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020
- Treatment with Convalescent Plasma for Influenza A (H5N1) Infection
- Therapeutic and triage strategies for 2019 novel coronavirus disease in fever clinics
- 2019-Novel Coronavirus (2019-nCoV): estimating the case fatality rate – a word of caution
- RNA vaccines: a novel technology to prevent and treat disease
- Correlation of Chest CT and RT-PCR Testing in Coronavirus Disease 2019 (COVID-19) in China: A Report of 1014 Cases
- Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China
- Clinical Characteristics of Coronavirus Disease 2019 in China
- Feasibility of controlling COVID-19 outbreaks by isolation of cases and contacts
- Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data
- Therapeutic strategies in an outbreak scenario to treat the novel coronavirus originating in Wuhan, China
- Positive RT-PCR Test Results in Patients Recovered From COVID-19
- Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target
- Zn2+ Inhibits Coronavirus and Arterivirus RNA Polymerase Activity In Vitro and Zinc Ionophores Block the Replication of These Viruses in Cell Culture
- The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus
- Systematic Comparison of Two Animal-to-Human Transmitted Human Coronaviruses: SARS-CoV-2 and SARS-CoV
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding
- Internet Book of Critical Care (IBCC) Covid-19
- Coronavirus: The Hammer and the Dance
- Clinical Outcomes in 55 Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Who Were Asymptomatic at Hospital Admission in Shenzhen, China